CEVA
CEVA, Inc.
CEVA's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CEVA overall, supported by stronger valuation and stronger fundamentals.
CEVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CEVA's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CEVA PE Valuation
CEVA has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CEVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
CEVA has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CEVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.74 | — |
| Q3 2026 | -$0.39 | +$0.07 |
| Q2 2026 | -$0.41 | +$0.01 |
| Q1 2026 | -$0.46 | -$0.18 |
| Q4 2025 | -$0.44 | -$0.07 |
| Q3 2025 | -$0.46 | -$0.32 |
| Q2 2025 | -$0.42 | -$0.13 |
| Q1 2025 | -$0.28 | +$0.25 |
| Q4 2024 | -$0.37 | +$0.14 |
CEVA is still losing money, but far less than before: $0.39 per share over the past year, against $1.34 at its worst in mid-2023.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CEVA on earnings quality, reporting a profit while its opponent remains loss making.
CEVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $29.1M | +2.4% |
| Q2 2026 | $29M | +13% |
| Q1 2026 | $27M | +11% |
| Q4 2025 | $31.3M | +7.1% |
| Q3 2025 | $28.4M | +4.3% |
| Q2 2025 | $25.7M | -9.7% |
| Q1 2025 | $24.2M | +9.8% |
| Q4 2024 | $29.2M | +21% |
CEVA's revenue has grown year over year for five quarters in a row: $29M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -4.8 points |
| Q2 2026 | -7.2% | +10 points |
| Q1 2026 | -19% | -0.8 points |
| Q4 2025 | -1.3% | -1.5 points |
| Q3 2025 | -7.3% | +2.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | -18% | +4.4 points |
| Q4 2024 | 0.3% | +12 points |
CEVA's operating margin was −12% last quarter, down 4.8 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CEVA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CEVA on profitability, with a higher operating margin.
CEVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $434K | +$6.7M |
| Q2 2026 | $5.2M | +955% |
| Q1 2026 | -$7.2M | +$515K |
| Q4 2025 | $7.2M | +3.1% |
| Q3 2025 | -$6.3M | -$6.3M |
| Q2 2025 | $492K | -72% |
| Q1 2025 | -$7.7M | +$539K |
| Q4 2024 | $7M | +73% |
CEVA's free cash flow has turned positive after three years mostly in the red: $6M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CEVA on cash flow, with more consistent year-over-year improvement.
CEVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +327K shares |
| 1 year | +18% | +4.4M shares |
| 3 years | +20% | +4.7M shares |
| 5 years | +22% | +5.2M shares |
| Available history | +27% | +6M shares |
CEVA has 28M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $988,000 |
| Q2 2025 | $6.2M |
| Q1 2025 | — |
| Q4 2024 | $1M |
| Q3 2024 | $4.2M |
| Q2 2024 | $2M |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CEVA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CEVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -42.2x | Net Cash |
| Q3 2022 | -8.0x | Net Cash |
| Q2 2022 | -2.0x | Net Cash |
| Q1 2022 | -3.5x | Net Cash |
| Q4 2021 | -3.5x | Net Cash |
| Q3 2021 | -3.3x | Net Cash |
| Q2 2021 | -3.2x | Net Cash |
| Q1 2021 | -10.5x | Net Cash |
CEVA has more cash than debt.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CEVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 25.4 | Neutral |
CEVA's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CEVA PE vs Technology Sector
| Metric | CEVA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CEVA has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CEVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.7 | 14% below |
| 20 week MA | $32.6 | 19% below |
| 50 week MA | $29.4 | 11% below |
| 100 week MA | $27.7 | 4.9% below |
| 200 week MA | $25.7 | 2.3% above |
CEVA has fallen below most of its moving averages, though it's still 2.3% above its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CEVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $42.2 | +56% |
| 2021 | $42.2 | $44.4 | +5.1% |
| 2022 | $44.4 | $25.9 | -42% |
| 2023 | $25.9 | $22.7 | -12% |
| 2024 | $22.7 | $32.4 | +43% |
| 2025 | $32.4 | $21.7 | -33% |
| 2026 YTD | $21.7 | $26.3 | +21% |
CEVA has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.